Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhashis Banerjee

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Annals of the Rheumatic Diseases|May 6, 2017
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritisPhilip J Mease, Alice B Gottlieb, Désirée van der Heijde, et al.
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Clinical Pharmacology in Drug Development|February 19, 2020
Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon-γ-Induced Protein 10, BMS-986184, in Healthy Participants to Guide Therapeutic DosingWeiguo Cai, Tarek A Leil, Leonid Gibiansky, et al.
Arthritis Research & Therapy|February 17, 2022
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abataceptHarris A Ahmad, Joshua F Baker, Philip G Conaghan, et al.
The Journal of Dermatology|March 11, 2025
Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trialsAkimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Plos One|August 14, 2025
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 miceMonica N Goodland, Subhashis Banerjee, Michael L Niehoff, et al.
European Radiology|May 20, 2023
Deep learning for detection of iso-dense, obscure masses in mammographically dense breastsKrithika Rangarajan, Pranjal Aggarwal, Dhruv Kumar Gupta, et al.
European Radiology|June 22, 2023
Correction: Deep learning for detection of iso-dense, obscure masses in mammographically dense breastsKrithika Rangarajan, Pranjal Aggarwal, Dhruv Kumar Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Annals of the Rheumatic Diseases|May 6, 2017
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritisPhilip J Mease, Alice B Gottlieb, Désirée van der Heijde, et al.
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Clinical Pharmacology in Drug Development|February 19, 2020
Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon-γ-Induced Protein 10, BMS-986184, in Healthy Participants to Guide Therapeutic DosingWeiguo Cai, Tarek A Leil, Leonid Gibiansky, et al.
Arthritis Research & Therapy|February 17, 2022
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abataceptHarris A Ahmad, Joshua F Baker, Philip G Conaghan, et al.
The Journal of Dermatology|March 11, 2025
Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trialsAkimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Plos One|August 14, 2025
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 miceMonica N Goodland, Subhashis Banerjee, Michael L Niehoff, et al.
European Radiology|May 20, 2023
Deep learning for detection of iso-dense, obscure masses in mammographically dense breastsKrithika Rangarajan, Pranjal Aggarwal, Dhruv Kumar Gupta, et al.
European Radiology|June 22, 2023
Correction: Deep learning for detection of iso-dense, obscure masses in mammographically dense breastsKrithika Rangarajan, Pranjal Aggarwal, Dhruv Kumar Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Pageof 12